SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000980
Filing Date
2019-08-30
Accepted
2019-08-30 16:19:42
Documents
14
Period of Report
2019-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528398_8k.htm   iXBRL 8-K 29447
2 EXHIBIT 10.1 tv528398_ex10-1.htm EX-10.1 616011
  Complete submission text file 0001410578-19-000980.txt   988192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20190827.xsd EX-101.SCH 3550
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20190827_def.xml EX-101.DEF 27930
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20190827_lab.xml EX-101.LAB 36790
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20190827_pre.xml EX-101.PRE 26160
8 EXTRACTED XBRL INSTANCE DOCUMENT tv528398_8k_htm.xml XML 5461
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 191069776
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences